Thus, this study hypothesized that suppression of LGI3 appears to be closely associated with impairment of skin barrier in AD, and treatment with LGI3 might be crucial to restore the damaged skin barrier in AD. This evidence concerns the gene LGI3 and Alzheimer disease.